Kenneth J. Kelley is Director at HALOZYME THERAPEUTICS INC (HTI). They have made 13 open-market trades across 1 company since 2007, most recently 2021-04-14.
CIK 0001291219
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $1.8M since 2012, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HALO | SELL | 2021-04-14 | 2021-04-14 | $45.00 | $225K | +8.7% | -7.4% | -3.3% |
| HALO | SELL | 2021-03-01 | 2021-03-01 | $45.34 | $227K | -4.2% | -9.3% | -10.0% |
| HALO | SELL | 2021-02-01 | 2021-02-01 | $48.11 | $469K | +4.1% | -12.3% | +3.1% |
| HALO | SELL | 2021-01-04 | 2021-01-04 | $42.89 | $417K | +11.6% | +13.1% | +1.8% |
| HALO | SELL | 2020-12-07 | 2020-12-07 | $41.00 | $1.4M | +5.8% | +8.2% | -1.7% |
| HALO | SELL | 2020-12-02 | 2020-12-02 | $41.00 | $1.3M | +3.4% | +4.7% | +11.2% |
| HALO | SELL | 2020-11-25 | 2020-11-27 | $41.41 | $1.2M | -1.3% | +5.1% | +18.2% |
| HALO | BUY | 2020-03-19 | 2020-03-19 | $14.23 | $1.5M | +19.8% | +31.8% | +56.4% |
| HALO | SELL | 2015-06-18 | 2015-06-22 | $21.00 | $420K | -40.6% | -1.7% | -1.7% |
| HALO | SELL | 2015-03-05 | 2015-03-09 | $15.33 | $613K | -40.6% | -1.7% | -1.7% |
| HALO | BUY | 2012-08-27 | 2012-08-28 | $5.70 | $114K | -40.6% | -1.7% | -1.7% |
| HALO | BUY | 2012-05-14 | 2012-05-16 | $7.49 | $150K | -40.6% | -1.7% | -1.7% |
| HALO | SELL | 2007-05-25 | 2007-05-25 | $10.26 | $229K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-05-18 | 2007-05-22 | $10.55 | $158K | -40.6% | -1.7% | -1.7% |
| HTI | SELL · 10b5-1 | 2007-05-07 | 2007-05-09 | $10.40 | $130K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-04-30 | 2007-05-01 | $10.32 | $258K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-04-23 | 2007-04-24 | $8.84 | $221K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-04-16 | 2007-04-17 | $9.07 | $227K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-04-09 | 2007-04-10 | $8.46 | $211K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-04-02 | 2007-04-04 | $8.05 | $201K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-03-27 | 2007-03-28 | $8.38 | $4K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-03-26 | 2007-03-28 | $8.37 | $205K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-03-19 | 2007-03-21 | $8.70 | $218K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-03-14 | 2007-03-16 | $7.96 | $199K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.